Delivery Order SPE2DB22D3004-SPE2DB25FRM38
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,349.84, is a delivery order for the supply of 4,568,105,478 units of Terbinafine HCL 250 mg tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,971.41 firm fixed-price delivery order is for the supply of 4,568,188,746 units of the prescription medication terbinafine hydrochloride 250 mg tablets. The contract has a performance period through May 9, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,351.52 delivery order contract is for the supply of Terbinafine Hydrochloride 250 mg Tablets, a medication used to treat fungal infections. The contract is not set-aside and is a firm fixed price arrangement with a completion date of June 9, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
- This federal contract award, valued at $5,141.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of the medication Terbinafine Hydrochloride 250 mg Tablet, with a completion date of May 28, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $9,008.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Terbinafine HCL 250 MG Tablet 30S, a pharmaceutical product, with a completion date of July 10, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,568,680,092 tablets of the drug Terbinafine Hydrochloride 250 mg, with a ceiling value of $96,937.31. The contract is a Firm Fixed Price Delivery Order and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,833.39 firm fixed-price delivery order is for the supply of Terbinafine HCl 250 mg tablets, a medication used to treat fungal infections. The contract is not set aside and represents a competitive award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,000.37 firm fixed price delivery order is for the supply of 90 tablet bottles of the medication Terbinafine Hydrochloride 250 mg. The contract has an ultimate completion date of July 17, 2025 and was competitively awarded without any set-aside designation. AmerisourceBergen...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract, with a ceiling value of $92,164.85, is for the delivery of terbinafine hydrochloride 250 mg tablets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is the prime...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Terbinafine Hydrochloride 250 mg tablets. The contract has a firm fixed price, a ceiling value of $16,668.45, and a performance period through June 25, 2025. It is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRM38Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.58 delivery order contract is for the supply of Terbinafine Hydrochloride 250 mg tablets, a medication used to treat fungal infections. The contract is a firm fixed-price, non-set-aside award with a period of performance through July 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which serves as a comprehensive global pharmaceutical support vehicle. The DLA plans to establish new Pharmaceutical Prime Vendor Global Program Generation V contracts, potentially involving multiple regional awards, allowing Amerisourcebergen Drug Corp to continue supplying a wide range of pharmaceutical products and medical supplies to support military and government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/16/25 |